HeLa cells also demonstrated increased apoptosis to GlcN/TRAIL treatment albeit not in the same magnitude as DU145 cells, whereas neither PC3 nor C4-2B prostate cancer cells responded to GlcN/TRAIL treatment under the same conditions (Supplemental Data Figure S1A). The gene discussed is TNFSF10; the disease is prostate carcinoma.